---
id: aha-perioperative-cv-2025
title: "2025 AHA/ACC Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery"
short_title: "Perioperative CV Evaluation"
organization: American Heart Association / American College of Cardiology
country: United States
url: https://www.ahajournals.org/doi/10.1161/CIR.0000000000001217
specialty: cardiology
guideline_type: clinical-practice
evidence_system: acc-aha
conditions:
  - Perioperative Cardiovascular Risk
  - Noncardiac Surgery Risk Assessment
tags:
  - perioperative
  - surgical risk
  - cardiovascular evaluation
  - preoperative assessment
publication_date: 2025-01-20
previous_version_date: 2014-08-01
status: current
supersedes: acc-aha-perioperative-2014
superseded_by: null
pdf_path: null
has_pdf: false
last_reviewed: 2025-01-01
---

## Scope

This guideline provides recommendations for cardiovascular evaluation and management of patients undergoing noncardiac surgery.

## Key Recommendations

### Risk Assessment
**Stepwise Approach:**
1. Urgency of surgery (emergency vs. elective)
2. Active cardiac conditions (ACS, decompensated HF, severe valvular disease, significant arrhythmias)
3. Surgical risk (low, intermediate, elevated)
4. Functional capacity (â‰¥4 METs adequate)
5. Clinical risk factors (RCRI)

### Revised Cardiac Risk Index (RCRI)
- History of ischemic heart disease
- History of heart failure
- History of cerebrovascular disease
- Diabetes requiring insulin
- Creatinine >2 mg/dL
- High-risk surgery

### Preoperative Testing
**ECG:**
- Consider for patients with known CAD, significant arrhythmia, or undergoing elevated-risk procedures

**Stress Testing:**
- Not routine
- Consider if poor functional capacity AND elevated-risk surgery AND results would change management

**Echocardiography:**
- If unexplained dyspnea
- Known HF with clinical change
- Known severe valvular disease needing assessment

### Coronary Revascularization
- Not recommended solely to reduce perioperative cardiac risk
- Follow standard indications for revascularization

### Medication Management
**Continue:**
- Beta-blockers (do not start de novo immediately preoperatively)
- Statins (beneficial perioperatively)

**Hold:**
- ACEi/ARB on day of surgery (consider holding)
- DAPT: Balance stent thrombosis vs. bleeding risk

### Special Populations
- Recent coronary stent: Delay elective surgery (minimum 30 days for BMS, 3-6 months for DES)
- Heart failure: Optimize preoperatively
- Severe aortic stenosis: Consider intervention before elective high-risk surgery

### Post-operative Monitoring
- Troponin for high-risk patients with symptoms or ECG changes
- Early ambulation and VTE prophylaxis
